Guggenheim Maintains Buy on Veracyte, Raises Price Target to $50
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $50.
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $50.